[18] With appropriate management and realistic expectations, most patients successfully navigate the first month and establish a foundation for sustained, clinically meaningful weight loss
The injections, which are administered by patients once a week at home, mimic the hormone glucagon-like peptide-1 (GLP-1) to slow the release of sugar into the bloodstream
For arthritis or chronic pain, discuss topical creams, ice therapy, or prescription alternatives with your healthcare team before reaching for NSAIDs
Heres what the research shows for weight loss: Tirzepatide Results: Average weight loss: 15-21% of starting body weight Up to 65% of people lost 10% or more of their weight About 31% of people lost 20% or more of their weight Semaglutide Results: Average weight loss: 13-16% of starting body weight Around 73% of people lost 5% or more of their weight About 58% of people lost 10% or more of their weight Real-World Results In real-world clinical settings, people taking tirzepatide were more likely to achieve significant weight loss milestones compared to those taking semaglutide
Now, that barrier has been removed